ArticleMolecular therapy. Oncology2024

Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.

Selene Ingusci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.